BioSig Tech. (BSGM) & Electrophysiology Sector - Again the sicker NIAID Grade 3 patients - BioSig Tech. (BSGM) & Electrophysiology Sector - InvestorVillage
BioSig Tech. (BSGM) & Electrophysiology Sector (related stock BSGM)
  • TECH UPDATE: Please accept our apologies for the delay in getting our "board visit & message view" counts to normalize. As you may have noticed, starting yesterday the "board stats" for individual message boards started to display clearly erroneous "member" and "guest" visit counts. Needless to say, we don't like having unreliable traffic stats on the site any more than you do. Please understand this was not by design or intention. It's a glitch that resulted from an apparent incompatibility with the legacy code and the recent deployment of new servers to tackle issues related to last month's outage. In order to give our web developer a chance to take a closer look at the glitch and come up with a viable solution, we have decided to leave the code up for now so she can have real-world data to work with (rather than just turn the counts off again). So it looks like we may have to live with these bad counts a little longer, but our expectation is to have this resolved by early next week, if not sooner. We appreciate your patience and understanding.  
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: BioSig Tech. (BSGM) & Electrophysiology Sector   /  Message Board  /  Read Message


Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1816 of 1871  at  9/25/2020 12:41:23 PM  by

Rob Cos

The following message was updated on 9/25/2020 1:33:47 PM.

 In response to msg 1812 by  gpg39
view thread

Re: Again the sicker NIAID Grade 3 patients

Company has heard from me multiple times and at least 10 large investors I know. Believe they are working on mulitple areas to renew confidence - believe this was rehearsed and re-rehearsed and for some reason he went off on tangents. 
Drug did not fail was not futile and did not have safety issues. The Grade 4 could not separate since all patients got better - sure not perfect but a lot better than if all got worse or didn't get better.  There was separation in the Grade 3 and we need un-blinding for more info. 
Insiders cannot buy now they are in a blackout until 10Q as is the norm. I think its very likely multiple board members will be buying on open market as soon as they can because I am told everyone in the company thinks the selloff is overdone . Also company continues to work on value drivers they have disclosed publicly including talks with med device companies as recently disclosed (guidance remains same) have been going on for months and sales and installations are coming as is TCAI EP live. 
My personal opinion is PURE EP is worth a lot more than the current market cap and will be worth multiples of it in 6 months and that if MMPD proceeds to Phase 3 the company will find a way to monetize the drug and a portion or all of the 69% they own of VCLR. I also do believe the company will clarify some things as you ask since everyone I know who has talked to them said that should be a priority.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 18     Views: 844
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
1817 Re: Again the sicker NIAID Grade 3 patients - Great Post...Thank You...Let The Turnaround Begin....EOM. gpg39 0 9/25/2020 3:50:51 PM

Financial Market Data provided by